Glantus Holdings plc
(''Glantus'' or the ''Company'' or the "Group")
H1 Trading Update
Glantus (AIM: GLAN), the provider of Accounts Payable ("AP") automation and analytics solutions announces a trading update for the six months ended 30 June 2023.
In the Company's full year results which were released on 30 June 2023, the Company announced the following:
· Trading in the new financial year has been ahead of management's expectations (all figures for 2023 below are unaudited):
o Jan - Apr 2023 revenues of c.€4.558m, adjusted EBITDA profit of c.€1.3m
o Momentum has continued with revenues for May 2023 being ahead of budget at €1.1m
o Realignment of cost base in 2022 has delivered much improved adjusted EBITDA so far in 2023
The Company is pleased confirm that these trends continued for the whole half year period and trading has remained strong. Given the Company has continued to trade ahead of budget, the Board expects that the Company will report half year results ahead of its expectations.
Further detail on trading in the first half will be provided with the Company' interim results which are expected to be announced in September 2023.
Enquiries:
| Glantus Holdings | |
| Maurice Healy, CEO | + 353 86 267 7800 |
| Shore Capital | |
| Nominated Advisor and Broker Patrick Castle / Tom Knibbs/ Lucy Bowden | + 44 207 408 4090 |
| Yellow Jersey PR | |
| Charles Goodwin / Annabelle Willis | +44 7747 788 221 |
About Glantus Holdings plc
Glantus Holdings (AIM: GLAN) Glantus is a global provider of accounts payable automation and analytics solutions. Glantus' mission is to harness technology to drive innovation, unlocking efficiencies in AP to maximise working capital for global enterprise organisations. The award-winning Glantus DataShark Platform connects all AP systems and suppliers on one agile platform, eliminating cost and delivering new revenue streams. We work in tandem with our partners to deliver joint enterprise digital transformation solutions. For more information see glantus.com.
Founded in 2014 and headquartered in Dublin, Glantus has offices in the United States, United Kingdom, Poland and Costa Rica.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.